在接受适当预防性治疗的真实世界人群中,无显著血管造影冠状动脉疾病的糖尿病患者与无糖尿病患者的心肌梗死风险相同
基于丹麦西部心脏登记处2003年1月1日至2012年12月31日接受冠状动脉造影的人群队列,纳入93,866例患者(12,544例[13.4%]患糖尿病),中位随访4.1年。无阻塞性冠状动脉疾病的糖尿病患者与无糖尿病患者相比,调整后死亡(RR 1.03 [95%CI 0.92-1.15])、心源性死亡(RR 1.21 [95%CI 0.90-1.64])和心肌梗死(RR 0.88 [95%CI 0.65-1.17])风险相同。无冠状动脉疾病的糖尿病患者他汀(75.3% vs. 46.0%)和阿司匹林(65.7% vs. 52.7%)治疗率高于无冠状动脉疾病的无糖尿病患者。
要点
- 无阻塞性冠状动脉疾病的糖尿病患者与无糖尿病患者调整后心梗风险相同(RR 0.88 [95%CI 0.65-1.17])。
- 无冠状动脉疾病的糖尿病患者他汀治疗率75.3%、阿司匹林治疗率65.7%,均高于无冠状动脉疾病的无糖尿病患者。
- 在真实世界中,无显著血管造影冠状动脉疾病的糖尿病患者接受高比例他汀和阿司匹林治疗时,心血管事件风险与无糖尿病患者相同。
核心结论
- 在真实世界人群中,无血管造影显著冠状动脉疾病的糖尿病患者在接受高比例他汀和阿司匹林治疗时,心血管事件风险与无糖尿病患者相同。
研究设计与样本
- 基于人群的队列研究,纳入丹麦西部心脏登记处2003年1月1日至2012年12月31日接受冠状动脉造影的患者,按阻塞性冠状动脉疾病和糖尿病的有无分层。
- 共纳入93,866例患者,其中12,544例(13.4%)在冠状动脉造影时患糖尿病,中位随访4.1年。
- 终点为死亡、心源性死亡和心肌梗死,以无糖尿病且无冠状动脉疾病的患者为参照组计算未调整和调整率比(RR)。
主要发现
- 无阻塞性冠状动脉疾病的糖尿病患者与无糖尿病患者调整后死亡风险相同(RR 1.03 [95%CI 0.92-1.15])、心源性死亡风险相同(RR 1.21 [95%CI 0.90-1.64])、心肌梗死风险相同(RR 0.88 [95%CI 0.65-1.17])。
- 无冠状动脉疾病的糖尿病患者他汀治疗率75.3% vs. 无冠状动脉疾病的无糖尿病患者46.0%,阿司匹林治疗率65.7% vs. 52.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The risk of myocardial infarction (MI) in patients with diabetes is greater than for patients without diabetes. Consequently, prophylactic treatment is recommended for patients with diabetes and risk factors for ischemic heart disease. We aimed to estimate the risk of adverse cardiac events in patients with and without diabetes with and without coronary artery disease (CAD) after coronary angiography (CAG). RESEARCH DESIGN AND METHODS: A population-based cohort of patients registered in the Western Denmark Heart Registry who underwent CAG between 1 January 2003 and 31 December 2012 was stratified according to the presence or absence of obstructive CAD and diabetes. End points were death, cardiac death, and MI. Unadjusted and adjusted rate ratios (RRs) were calculated by using patients without diabetes and without CAD as the reference group. RESULTS: We included 93,866 patients of whom 12,544 (13.4%) had diabetes at the time of CAG. Median follow-up was 4.1 years. Patients with and without diabetes without obstructive CAD had the same adjusted risk of death (RR 1.03 [95% CI 0.92-1.15]), cardiac death (RR 1.21 [95% CI 0.90-1.64]), and MI (RR 0.88 [95% CI 0.65-1.17]). Patients with diabetes without CAD were more often treated with statins (75.3% vs. 46.0%) and aspirin (65.7% vs. 52.7%) than patients without diabetes and CAD. CONCLUSIONS: In a real-world population, patients with diabetes with high rates of statin and aspirin treatment had the same risk of cardiovascular events as patients without diabetes in the absence of angiographically significant CAD.
引用
- Olesen KKW, Madsen M, Egholm G, et al. Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment. Diabetes Care. 2017. PMID: 28596210. doi:10.2337/dc16-2388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。